ConductScience.org, home

Gene · 5214

Papers1,761

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Vitexin inhibits renal cell carcinoma progression by targeting Galectin-1-mediated glycolytic metabolism.Mol Biol Rep202642113369PubTator, text miningPubMed
Pestivirus bovine viral diarrhea virus infection induces ROS-HIF-1a axis-driven glycolytic reprogramming, which increases viral replication by impairing RIG-I-dependent type I interferon response.J Virol202642095650PubTator, text miningPubMed
Isoliquiritigenin Impedes Breast Cancer Progression through PITX1-PFKP-Mediated Glycolysis Reprogramming.Oncol Res202642065039PubTator, text miningPubMed
Platelet-Type Phosphofructokinase Drives Immune Checkpoint Coexpression and Metabolic Pathway Activation in Liver Cancer: The Cancer Genome Atlas-Based and Experimental Validation.Clin Transl Gastroenterol202642044203PubTator, text miningPubMed
PFKP is required for chemoresistant phenotype of breast cancer through modulating the formation of CD133+ cancer stem like cells.Mol Biomed202642024199PubTator, text miningPubMed
ATM promotes PFKP nuclear translocation to balance glycolysis and homologous recombination repair.Nucleic Acids Res202642011782PubTator, text miningPubMed
Molecular mechanisms of DBDPE-induced spermatogenic disorder: A network toxicology, machine learning, and in vivo experimental validation.Environ Int202641941847PubTator, text miningPubMed
Identification of STMN1 as a lactylation‑related driver of lung cancer progression using Mendelian randomization.Mol Med Rep202641930463PubTator, text miningPubMed
Unveiling lactylation: A novel frontier in the pathogenesis of diabetic nephropathy (Review).Int J Mol Med202641891971PubTator, text miningPubMed
Uncovering the metabolic-epigenetic links between gene expression and stroke: insights from lactylation pathway MR study.Neurol Res Pract202641877258PubTator, text miningPubMed
Glyphosate-Induced Metabolic and Immune Modulation in Hepatoma Cells: Identification of Key Genes as Diagnostic and Therapeutic Targets Using an In Silico Systems Biology Approach.J Xenobiot202641874122PubTator, text miningPubMed
Neuroprotective response against the onset of ischemic stroke by upregulation of histone H3Y99 sulfation.Cell Rep Med202641850229PubTator, text miningPubMed
The c-Myc-USP14-PFKP axis sustains chemoresistance in pancreatic ductal adenocarcinoma.Drug Resist Updat202641812332PubTator, text miningPubMed
Leveraging proteomics and machine learning for mechanism and biomarker discovery on glioma progression and transformation: from LGG to GBM.Hum Genomics202641807981PubTator, text miningPubMed
Comparison of glucose concentrations in simultaneously collected plasma and serum samples from outpatients in a routine laboratory setting.PLoS One202641805779PubTator, text miningPubMed
Mitochondrial-targeted therapy for osteoarthritis: Challenges and opportunities from basic research to clinical translation.Front Immunol202641798918PubTator, text miningPubMed
Salvianolic acid C alleviates acute kidney injury by restoring fructose-1,6-bisphosphatase 1-mediated gluconeogenesis.Ren Fail202641795894PubTator, text miningPubMed
Decreased Glucose Metabolism and Declined Chaperones Are Unique Features Required for the Survival of Senescent Fibroblasts and Pyruvate Dehydrogenase Is a Potent Senolytic Target.Aging Cell202641786630PubTator, text miningPubMed
The mechanisms of energy balance between oxidative phosphorylation and glycolysis in human ovarian granulosa cells.Front Physiol202641778198PubTator, text miningPubMed
The crosstalk between nerves and immunity: chronic stress as a driver of tumor progression.Front Immunol202641777893PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/5214/papers?page=2